JP2020504186A5 - - Google Patents

Download PDF

Info

Publication number
JP2020504186A5
JP2020504186A5 JP2019557681A JP2019557681A JP2020504186A5 JP 2020504186 A5 JP2020504186 A5 JP 2020504186A5 JP 2019557681 A JP2019557681 A JP 2019557681A JP 2019557681 A JP2019557681 A JP 2019557681A JP 2020504186 A5 JP2020504186 A5 JP 2020504186A5
Authority
JP
Japan
Prior art keywords
acetonitrile
cyclohexyl
pyridin
imidazole
hydroxyethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019557681A
Other languages
English (en)
Japanese (ja)
Other versions
JP7009504B2 (ja
JP2020504186A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/050548 external-priority patent/WO2018130563A1/en
Publication of JP2020504186A publication Critical patent/JP2020504186A/ja
Publication of JP2020504186A5 publication Critical patent/JP2020504186A5/ja
Application granted granted Critical
Publication of JP7009504B2 publication Critical patent/JP7009504B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019557681A 2017-01-11 2018-01-10 ヤヌスキナーゼ阻害剤としての新規アミノイミダゾピリジン誘導体及びそれらの医薬としての使用 Active JP7009504B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17151020 2017-01-11
EP17151020.9 2017-01-11
PCT/EP2018/050548 WO2018130563A1 (en) 2017-01-11 2018-01-10 Novel amino-imidazopyridine derivatives as janus kinase inhibitors and pharmaceutical use thereof

Publications (3)

Publication Number Publication Date
JP2020504186A JP2020504186A (ja) 2020-02-06
JP2020504186A5 true JP2020504186A5 (cg-RX-API-DMAC7.html) 2021-02-12
JP7009504B2 JP7009504B2 (ja) 2022-01-25

Family

ID=57777557

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019557681A Active JP7009504B2 (ja) 2017-01-11 2018-01-10 ヤヌスキナーゼ阻害剤としての新規アミノイミダゾピリジン誘導体及びそれらの医薬としての使用

Country Status (26)

Country Link
US (1) US10703751B2 (cg-RX-API-DMAC7.html)
EP (1) EP3568396B1 (cg-RX-API-DMAC7.html)
JP (1) JP7009504B2 (cg-RX-API-DMAC7.html)
KR (1) KR102548543B1 (cg-RX-API-DMAC7.html)
CN (1) CN110167938B (cg-RX-API-DMAC7.html)
AU (1) AU2018208516B2 (cg-RX-API-DMAC7.html)
CA (1) CA3045567A1 (cg-RX-API-DMAC7.html)
CY (1) CY1123864T1 (cg-RX-API-DMAC7.html)
DK (1) DK3568396T3 (cg-RX-API-DMAC7.html)
ES (1) ES2846741T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20210095T1 (cg-RX-API-DMAC7.html)
HU (1) HUE052720T2 (cg-RX-API-DMAC7.html)
IL (1) IL267829B (cg-RX-API-DMAC7.html)
LT (1) LT3568396T (cg-RX-API-DMAC7.html)
MX (1) MX389378B (cg-RX-API-DMAC7.html)
MY (1) MY195576A (cg-RX-API-DMAC7.html)
NZ (1) NZ754922A (cg-RX-API-DMAC7.html)
PL (1) PL3568396T3 (cg-RX-API-DMAC7.html)
PT (1) PT3568396T (cg-RX-API-DMAC7.html)
RS (1) RS61317B1 (cg-RX-API-DMAC7.html)
RU (1) RU2019125177A (cg-RX-API-DMAC7.html)
SI (1) SI3568396T1 (cg-RX-API-DMAC7.html)
TW (1) TWI760419B (cg-RX-API-DMAC7.html)
UA (1) UA123972C2 (cg-RX-API-DMAC7.html)
WO (1) WO2018130563A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201904190B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190144A1 (ar) 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
EP4086256A1 (en) 2016-12-16 2022-11-09 Janssen Pharmaceutica NV Small molecule inhibitors of the jak family of kinases
TW202016110A (zh) 2018-06-15 2020-05-01 比利時商健生藥品公司 Jak激酶家族之小分子抑制劑
CN112384514A (zh) * 2018-07-06 2021-02-19 利奥制药有限公司 作为janus激酶抑制剂的新的氨基-咪唑并嘧啶衍生物及其药物用途
CN114555595B (zh) * 2019-08-30 2023-12-26 Tsd生命科学有限公司 咪唑并吡啶衍生物及将其作为有效成分的药学组合物
CA3213134A1 (en) 2021-03-11 2022-09-15 Janssen Pharmaceutica Nv Lorpucitinib for use in the treatment of jak mediated disorders
CN119569971B (zh) * 2025-02-07 2025-05-27 吉林大学 一种用于蛋白质磷酸化和棕榈酰化修饰同时筛选的Janus材料的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101981033B (zh) * 2008-02-06 2015-02-04 百时美施贵宝公司 用作激酶抑制剂的取代的咪唑并哒嗪化合物
US8461328B2 (en) * 2010-01-12 2013-06-11 Genentech, Inc. Tricyclic heterocyclic compounds, compositions and methods of use thereof
CN103168032A (zh) * 2010-08-05 2013-06-19 安美基公司 抑制间变性淋巴瘤激酶的苯并咪唑和氮杂苯并咪唑化合物
EP2518071A1 (en) * 2011-04-29 2012-10-31 Almirall, S.A. Imidazopyridine derivatives as PI3K inhibitors
EP2527344A1 (en) * 2011-05-25 2012-11-28 Almirall, S.A. Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
WO2013007768A1 (en) * 2011-07-13 2013-01-17 F. Hoffmann-La Roche Ag Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors
WO2013007765A1 (en) 2011-07-13 2013-01-17 F. Hoffmann-La Roche Ag Fused tricyclic compounds for use as inhibitors of janus kinases
UY34616A (es) * 2012-02-10 2013-09-30 Galapagos Nv Nuevo compuesto útil para el tratamiento de enfermedades degenerativas e inflamatorias.
UA117572C2 (uk) 2012-11-01 2018-08-27 Інсайт Холдинґс Корпорейшн Трициклічні конденсовані похідні тіофену як інгібітори jak
EP3181564B1 (en) * 2012-11-20 2019-09-18 H. Hoffnabb-La Roche Ag Aminopyrimidine compounds as inhibitors of t790m containing egfr mutants
CN104098563A (zh) * 2013-04-02 2014-10-15 山东亨利医药科技有限责任公司 Jnk抑制剂化合物
TW201625643A (zh) * 2014-04-30 2016-07-16 英塞特公司 製備jak1抑制劑之方法及其新形式
PT3509591T (pt) 2016-10-03 2021-12-27 Highlightll Pharmaceutical Hainan Co Ltd Novos inibidores seletivos da jak1 e usos dos mesmos
JOP20190144A1 (ar) 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز

Similar Documents

Publication Publication Date Title
JP2020504186A5 (cg-RX-API-DMAC7.html)
AU2023201399B2 (en) Modulators of the integrated stress pathway
JP2014513110A5 (cg-RX-API-DMAC7.html)
TWI810582B (zh) 酪胺酸激酶抑制劑
JP2020183410A5 (cg-RX-API-DMAC7.html)
JP2017526726A5 (cg-RX-API-DMAC7.html)
JP2016522835A5 (cg-RX-API-DMAC7.html)
JP2020505395A5 (cg-RX-API-DMAC7.html)
JP2017509689A5 (cg-RX-API-DMAC7.html)
JP2016527238A5 (cg-RX-API-DMAC7.html)
JP2013542256A5 (cg-RX-API-DMAC7.html)
JP2014139226A5 (cg-RX-API-DMAC7.html)
RU2019125177A (ru) Новые производные амино-имидазопиридина в качестве ингибиторов янус-киназы и их фармацевтическое применение
JP2018537535A5 (cg-RX-API-DMAC7.html)
JP2013542261A5 (cg-RX-API-DMAC7.html)
JP2019525939A5 (cg-RX-API-DMAC7.html)
JP2008510770A5 (cg-RX-API-DMAC7.html)
JP2019505541A5 (cg-RX-API-DMAC7.html)
JP2011500758A5 (cg-RX-API-DMAC7.html)
JP2012532112A5 (cg-RX-API-DMAC7.html)
JP2017531038A5 (cg-RX-API-DMAC7.html)
JP2017524025A5 (cg-RX-API-DMAC7.html)
JP2009538910A5 (cg-RX-API-DMAC7.html)
JP2022017461A5 (cg-RX-API-DMAC7.html)
CN105473573A (zh) 用作激酶抑制剂的咔唑甲酰胺化合物